The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 18, 2022

Filed:

Oct. 22, 2014
Applicant:

Translate Bio, Inc., Cambridge, MA (US);

Inventors:

Michael Heartlein, Lexington, MA (US);

Frank DeRosa, Lexington, MA (US);

Lianne Smith, Lexington, MA (US);

Assignee:

Translate Bio, Inc., Lexington, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/7088 (2006.01); A61K 9/127 (2006.01); A61K 38/53 (2006.01); C12N 9/00 (2006.01); A61K 48/00 (2006.01); A61K 9/51 (2006.01); A61K 31/7105 (2006.01);
U.S. Cl.
CPC ...
A61K 38/53 (2013.01); A61K 9/1272 (2013.01); A61K 9/5123 (2013.01); A61K 31/7105 (2013.01); C12N 9/93 (2013.01); C12Y 603/04005 (2013.01); A61K 48/00 (2013.01); A61K 48/005 (2013.01);
Abstract

The present invention provides, among other things, methods of treating Argininosuccinate Synthetase Deficiency (ASD), including administering to a subject in need of treatment a composition comprising an mRNA encoding argininosuccinate synthetase (ASS1) at an effective dose and an administration interval such that at least one symptom or feature of ASD is reduced in intensity, severity, or frequency or has delayed in onset. In some embodiments, the mRNA is encapsulated in a liposome comprising one or more cationic lipids, one or more non-cationic lipids, one or more cholesterol-based lipids and one or more PEG-modified lipids.


Find Patent Forward Citations

Loading…